Journal of Clinical & Experimental OncologyISSN: 2324-9110

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Imad AlSabri Author

zuhair.allabban@uokufa.edu.iq

Subjects of specialization
Mucoepidermoid carcinoma, Cancer chemotherapy, Prostate biomarker, Endometrial cancer

Affiliation
Middle Euphrates Cancer Therapy Center, Najaf, Iraq and Middle Euphrates Unit for Cancer Research, College of Medicine, University of Kufa, Najaf, Iraq

Biography

Imad AlSabri was working in the Middle Euphrates Cancer Therapy Center, Najaf, Iraq and also worked at Middle Euphrates Unit for Cancer Research, College of Medicine, University of Kufa, Najaf, Iraq. 

Publications

Research Article Open Access

Prognostic Markers in Osteosarcoma Patients in the Najaf Province of Iraq

Author(s):

Hamdallah H Al-Baseesee, Imad AlSabri, Amina B Aldujele and Zuhair Allebban*

Background: Among the solid malignancies of bone, osteosarcomas are the most common, but unfortunately there has not been solid new therapy for this disease. In this study, we emphasized on the prognostic markers of the disease and our goal was to present the clinical and demographic outcomes of osteosarcoma patients.

Materials and Methods: A total of 30 patients (17 male, 13 female) osteosarcoma patients treated and followed up in Middle Euphrates Cancer Center Therapy in Najaf, Iraq from 2016 to 2017 were reviewed prospectively and retrospectively. Serum alkaline phosphatase (ALP), lactate dehydrogenase (LDH) and bone-specific ALP (bsALP) were analyzed both before and after chemotherapy... view more»

DOI: 10.4172/2324-9110.1000215

Abstract HTML PDF

Google Scholars / Researchers Sites

Explore SciTechnol

GET THE APP